Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence evaluation of voriconazole 200 mg tablets under fasting condition
TCTR20181220006Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of voriconazole (2 arms), sponsored by Bio-innova. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
voriconazole
Beyond the preview
Go deeper on TCTR20181220006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20181220006.